Logo image of AMTBB

Mercantil Bank Holding Cl B (AMTBB) Stock Fundamental Analysis

NASDAQ:AMTBB - Nasdaq -

28.72  -0.33 (-1.14%)

Fundamental Rating

2

Overall AMTBB gets a fundamental rating of 2 out of 10. We evaluated AMTBB against 395 industry peers in the Banks industry. AMTBB has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, AMTBB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AMTBB was profitable.
AMTBB Yearly Net Income VS EBIT VS OCF VS FCFAMTBB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 20M 40M 60M

1.2 Ratios

Industry RankSector Rank
ROA 0.75%
ROE 6.87%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMTBB Yearly ROA, ROE, ROICAMTBB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 2 4 6

1.3 Margins

The Operating Margin and Gross Margin are not available for AMTBB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 22.12%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMTBB Yearly Profit, Operating, Gross MarginsAMTBB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 5 10 15

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for AMTBB has been reduced compared to 1 year ago.
AMTBB has a worse debt/assets ratio than last year.
AMTBB Yearly Shares OutstandingAMTBB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 10M 20M 30M 40M
AMTBB Yearly Total Debt VS Total AssetsAMTBB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2B 4B 6B 8B

2.2 Solvency

A Debt/Equity ratio of 0.15 indicates that AMTBB is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
AMTBB Yearly LT Debt VS Equity VS FCFAMTBB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 200M 400M 600M 800M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1937.50% over the past year.
AMTBB shows a decrease in Revenue. In the last year, the revenue decreased by -6.38%.
AMTBB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.99% yearly.
EPS 1Y (TTM)1937.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
Revenue 1Y (TTM)-6.38%
Revenue growth 3Y-2.19%
Revenue growth 5Y2.99%
Sales Q2Q%-0.59%

3.2 Future

The Earnings Per Share is expected to grow by 99.39% on average over the next years. This is a very strong growth
AMTBB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.84% yearly.
EPS Next Y1788.1%
EPS Next 2Y361.65%
EPS Next 3Y190.61%
EPS Next 5Y99.39%
Revenue Next Year-2.71%
Revenue Next 2Y1.88%
Revenue Next 3Y3.88%
Revenue Next 5Y4.84%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMTBB Yearly Revenue VS EstimatesAMTBB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
AMTBB Yearly EPS VS EstimatesAMTBB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.54, AMTBB is valued on the expensive side.
When comparing the Price/Earnings ratio of AMTBB to the average of the S&P500 Index (24.85), we can say AMTBB is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 14.87, the valuation of AMTBB can be described as correct.
The average S&P500 Price/Forward Earnings ratio is at 20.89. AMTBB is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.54
Fwd PE 14.87
AMTBB Price Earnings VS Forward Price EarningsAMTBB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMTBB Per share dataAMTBB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AMTBB's earnings are expected to grow with 190.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y361.65%
EPS Next 3Y190.61%

More info and screens

0

5. Dividend

5.1 Amount

AMTBB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Mercantil Bank Holding Cl B

NASDAQ:AMTBB (11/17/2021, 8:16:39 PM)

28.72

-0.33 (-1.14%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)N/A N/A
Earnings (Next)01-20 2022-01-20
Inst Owners0.03%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.08B
Analysts80
Price Target30.41 (5.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 19.54
Fwd PE 14.87
P/S 4.26
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB N/A
EV/EBITDA N/A
EPS(TTM)1.47
EY5.12%
EPS(NY)1.93
Fwd EY6.72%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.74
BVpS21.7
TBVpSN/A
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.75%
ROE 6.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 22.12%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1937.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
EPS Next Y1788.1%
EPS Next 2Y361.65%
EPS Next 3Y190.61%
EPS Next 5Y99.39%
Revenue 1Y (TTM)-6.38%
Revenue growth 3Y-2.19%
Revenue growth 5Y2.99%
Sales Q2Q%-0.59%
Revenue Next Year-2.71%
Revenue Next 2Y1.88%
Revenue Next 3Y3.88%
Revenue Next 5Y4.84%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A